Aclaris Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 12.72 M | $67.30 M | 86.99% | 9.88% |
| BML CAPITAL MANAGEMENT, LLC | 08/07/2026 | 11.98 M | $63.35 M | -15.96% | 9.30% |
| BLACKROCK, INC. | 08/07/2026 | 10.04 M | $53.10 M | 35.51% | 7.79% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 9.35 M | $49.44 M | 0.00% | 7.25% |
| VIVO CAPITAL, LLC | 08/14/2026 | 6.69 M | $35.41 M | 0.42% | 5.20% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 5.82 M | $30.78 M | 12.59% | 4.52% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 4.93 M | $26.06 M | 0.00% | 3.82% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 4.33 M | $22.91 M | -3.18% | 3.36% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 4.07 M | $21.54 M | 5.17% | 3.16% |
| DECHENG CAPITAL LLC | 08/14/2026 | 4.04 M | $21.38 M | 0.00% | 3.14% |
| STATE STREET CORP | 08/07/2026 | 3.26 M | $17.22 M | 62.06% | 2.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 3.19 M | $16.88 M | 31.62% | 2.48% |
| BRAIDWELL LP | 08/14/2026 | 2.14 M | $11.33 M | 26.09% | 1.66% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 2.02 M | $10.70 M | -39.80% | 1.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 1.95 M | $10.30 M | 100.00% | 1.51% |
| KALEHUA CAPITAL MANAGEMENT LLC | 08/19/2026 | 1.83 M | $9.69 M | 0.00% | 1.42% |
| CITADEL ADVISORS LLC | 08/14/2026 | 1.76 M | $9.32 M | -21.66% | 1.37% |
| JONES HILL CAPITAL LP | 08/13/2026 | 1.76 M | $9.31 M | 100.00% | 1.37% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 1.64 M | $8.68 M | 6.60% | 1.27% |
| PALO ALTO INVESTORS LP | 08/19/2026 | 1.61 M | $8.54 M | 0.00% | 1.25% |
| WOODLINE PARTNERS LP | 08/14/2026 | 1.61 M | $8.52 M | 8.44% | 1.25% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.47 M | $7.75 M | -11.49% | 1.14% |
| PANAGORA ASSET MANAGEMENT INC | 08/06/2026 | 1.36 M | $7.17 M | 169.99% | 1.05% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 1.21 M | $6.40 M | -14.70% | 0.94% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 1.04 M | $5.51 M | 165.99% | 0.81% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 1.04 M | $5.51 M | 4.32% | 0.81% |
| NORTHERN TRUST CORP | 08/13/2026 | 998.76 K | $5.28 M | 37.15% | 0.78% |
| ALDEBARAN CAPITAL, LLC | 08/14/2026 | 936.73 K | $4.96 M | -1.10% | 0.73% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 907.17 K | $4.80 M | 44.26% | 0.70% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 817.53 K | $4.32 M | 62.65% | 0.63% |
| THREE BRIDGE WEALTH ADVISORS, LLC | 07/27/2026 | 714.82 K | $3.78 M | 0.00% | 0.55% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 609.16 K | $3.22 M | 3.48% | 0.47% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 523.90 K | $2.77 M | -30.71% | 0.41% |
| CITADEL ADVISORS LLC | 08/14/2026 | 521.00 K | $2.76 M | 11.71% | 0.40% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 513.84 K | $2.71 M | 0.47% | 0.40% |
| JPMORGAN CHASE & CO | 08/12/2026 | 468.96 K | $2.35 M | -3.63% | 0.36% |
| AISLING CAPITAL MANAGEMENT LP | 08/13/2026 | 434.46 K | $2.30 M | 0.00% | 0.34% |
| BOLLARD GROUP LLC | 08/12/2026 | 431.63 K | $2.28 M | 0.00% | 0.34% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 421.50 K | $2.23 M | 100.00% | 0.33% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 414.50 K | $2.19 M | -53.99% | 0.32% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 412.55 K | $2.18 M | 8.59% | 0.32% |
| TFG ASSET MANAGEMENT GP LTD | 08/13/2026 | 400.00 K | $2.12 M | 100.00% | 0.31% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 365.06 K | $1.93 M | 18.46% | 0.28% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 346.06 K | $1.83 M | 32.59% | 0.27% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 346.06 K | $1.83 M | 100.00% | 0.27% |
| FMR LLC | 08/13/2026 | 313.85 K | $1.66 M | 77.97% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 282.60 K | $1.49 M | 36.51% | 0.22% |
| NUVEEN, LLC | 08/11/2026 | 278.40 K | $1.47 M | 135.90% | 0.22% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 275.61 K | $1.46 M | 3.44% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 267.50 K | $1.42 M | 4.02% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aclaris Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 198 institutional investors and hedge funds held shares of Aclaris Therapeutics Inc. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 12.72 M
BML Capital Management, LLC: 11.98 M
BlackRock, Inc.: 10.04 M
Deep Track Capital, LP: 9.35 M
Vivo Capital, LLC: 6.69 M
VANGUARD CAPITAL MANAGEMENT LLC: 5.82 M
92.76% of Aclaris Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 135.08 M shares in the last 24 months. This purchase volume represents approximately $457.91 M in transactions.